Ubiquitin Immunohistochemistry Suggests Classic Motor Neuron Disease, Motor Neuron Disease With Dementia, and Frontotemporal Dementia of the Motor Neuron Disease Type Represent a Clinicopathologic Spectrum

Abstract One of the characteristic pathologic changes in classic motor neuron disease (MND) is the presence of ubiquitin-immunoreactive (ub-ir) inclusions in the cytoplasm of lower motor neurons. In addition, cases of MND with dementia (MND-d) also have ub-ir neuronal cytoplasmic inclusions and dystrophic neurites in extramotor neocortex and hippocampus. Although this extramotor pathology is a highly sensitive marker for dementia in MND, similar changes are found in a subset of patients with frontotemporal dementia (FTD) with no motor symptoms (FTD-MND type). The purpose of this study is to more fully describe and compare the pattern of ub-ir pathology in these 3 conditions. We performed ubiquitin immunohistochemistry on postmortem tissue, representing a wide range of neuroanatomic structures, in cases of classic MND (n = 20), MND-d (n = 15), and FTD-MND type (n = 15). We found the variety of morphologies and the anatomic distribution of ub-ir pathology to be greater than previously documented. Moreover, the degree of overlap suggests that MND, MND-d, and FTD-MND type represent a spectrum of clinical disease with a common pathologic substrate. The only finding restricted to a specific subgroup of patients was the presence of ub-ir neuronal intranuclear inclusions in some cases of familial FTD.

[1]  J. Trojanowski,et al.  Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease , 2004, Neurology.

[2]  M. Mesulam,et al.  Neuronal Ubiquitinated Intranuclear Inclusions in Familial and Non‐Familial Frontotemporal Dementia of the Motor Neuron Disease Type Associated with Amyotrophic Lateral Sclerosis , 2004, Journal of neuropathology and experimental neurology.

[3]  H. Feldman,et al.  Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study , 2004, Acta Neuropathologica.

[4]  B. Miller,et al.  Are amyotrophic lateral sclerosis patients cognitively normal? , 2003, Neurology.

[5]  H. Feldman,et al.  Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases , 2003, Acta Neuropathologica.

[6]  H. Feldman,et al.  The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease , 2003, Acta Neuropathologica.

[7]  Catherine Lomen-Hoerth,et al.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.

[8]  C. Duijn,et al.  Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval , 2002, Molecular Psychiatry.

[9]  Odette A. Harris,et al.  The role of hypothermia in the management of severe brain injury: a meta-analysis. , 2002, Archives of neurology.

[10]  S. Al-Sarraj,et al.  Ubiquitin‐only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neurone disease with dementia , 2002, Neuropathology and applied neurobiology.

[11]  J. Trojanowski,et al.  Update on the Neuropathological Diagnosis of Frontotemporal Dementias , 2001, Journal of neuropathology and experimental neurology.

[12]  T. Iwaki,et al.  Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum , 2001, Acta Neuropathologica.

[13]  W. Kamphorst,et al.  Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. , 2001, Brain : a journal of neurology.

[14]  D. Munoz,et al.  Cognitive impairment in sporadic ALS , 2001, Neurology.

[15]  Andrew Kertesz,et al.  Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions , 2001, Acta Neuropathologica.

[16]  A. Kakita,et al.  Ubiquitinated neuronal inclusions in the neostriatum in patients with amyotrophic lateral sclerosis with and without dementia--a study of 60 patients 31 to 87 years of age. , 2001, Clinical neuropathology.

[17]  G. Leuba,et al.  Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease , 2000, Acta Neuropathologica.

[18]  Y. Yoshida,et al.  Nigral degeneration in a case of amyotrophic lateral sclerosis: evidence of Lewy body-like and skein-like inclusions in the pigmented neurons. , 1999, Clinical neuropathology.

[19]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[20]  J. Slade,et al.  Amyotrophic Lateral Sclerosis Associated with Genetic Abnormalities in the Gene Encoding Cu/Zn Superoxide Dismutase: Molecular Pathology of Five New Cases, and Comparison with Previous Reports and 73 Sporadic Cases of ALS , 1998, Journal of neuropathology and experimental neurology.

[21]  J. Lowe,et al.  Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. , 1998, Neuropathology and applied neurobiology.

[22]  J. Lowe,et al.  Motor neurone disease-inclusion dementia. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[23]  P. Massman,et al.  Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[24]  D. Mann,et al.  τ Ubiquitin, and αB-Crystallin Immunohistochemistry Define the Principal Causes of Degenerative Frontotemporal Dementia , 1995 .

[25]  N. Cairns,et al.  Involvement of the amygdala, dentate and hippocampus in motor neuron disease , 1995, Journal of the Neurological Sciences.

[26]  D. Neary,et al.  Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[27]  J. Lowe New pathological findings in amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[28]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[29]  R. Currier,et al.  Decreased insulin-like growth factor I-mediated protein tyrosine phosphorylation in human olivopontocerebellar atrophy and lurcher mutant mouse , 1994, Journal of the Neurological Sciences.

[30]  P N Leigh,et al.  The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. , 1993, Brain : a journal of neurology.

[31]  S. Hirai,et al.  Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease , 1992, Journal of Neurology.

[32]  Bradley T. Hyman,et al.  Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.

[33]  D. Neary,et al.  Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia , 1992, Neuroscience Letters.

[34]  Peter Davies,et al.  Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.

[35]  H. Herzog,et al.  Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study , 1992, Acta neurologica Scandinavica.

[36]  Yoichi Nakazato,et al.  New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis , 1991, Neuroscience Letters.

[37]  M. Swash,et al.  Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. , 1991, Brain : a journal of neurology.

[38]  D. Dickson,et al.  Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[39]  D. Dickson,et al.  UBIQUITIN IMMUNOREACTIVE STRUCTURES IN NORMAL BRAINS: DISTRIBUTION AND DEVELOPMENTAL ASPECTS , 1990 .

[40]  A. Stracciari,et al.  Cognitive impairment in motor neuron disease , 1985, Acta neurologica Scandinavica.

[41]  A. Hudson Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. , 1981, Brain : a journal of neurology.

[42]  A. Hirano,et al.  Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. , 1967, Archives of neurology.

[43]  I. Mackenzie Senile plaques do not progressively accumulate with normal aging , 2004, Acta Neuropathologica.